The Global MPN Scientific Foundation acknowledges the significant challenges in managing myeloproliferative neoplasms (MPN), including a lack of awareness among patients and healthcare providers, limited access to specialized testing and care, and variability in diagnostic criteria and treatment guidelines.

Additionally, there is a scarcity of effective therapies and clinical trials. The foundation, operated by dedicated volunteers, offers a wealth of unbiased, medically backed information, supports ongoing research, and helps build a strong MPN community.

They actively encourage patients, physicians, and pharmaceutical representatives to join their mission to enhance the quality of life for those affected by MPN. Together, they aim to drive progress in understanding and treating this rare group of blood cancers.